StocksFin Logo
High Tide Inc. country of incorporation
|
|
996 employees
NASDAQ | Healthcare | Pharmaceutical Retailers
Harvard Bioscience, Inc. country of incorporation
|
|
Mr. James Green
|
475 employees
NASDAQ | Healthcare | Medical Instruments & Supplies
Q322 reported Jul 31, 2022 Reporting Period
$95.35M 98.4% vs. Q321 Revenues Q322
27.01% -22.2% vs. Q321 Gross Profit Margin
-2.44% ! 35.4% vs. Q321 Net Profit Margin
-2.87M ! 45.1% vs. Q321 Free Cash Flow Q322
$-0.04 ! -33.3% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 9, 2022 Reporting Period
$26.92M -9.2% vs. Q321 Revenues Q322
45.21% -17.8% vs. Q321 Gross Profit Margin
-12.65% ! -2106.9% vs. Q321 Net Profit Margin
207k 131.4% vs. Q321 Free Cash Flow Q322
$-0.08 ! -1804.8% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Ratios
As of
Oct 31, 2022
Sep 30, 2022
Quick Ratio
0.56
0.94
Current Ratio
1.07
2.43
Cash Ratio
0.42
0.24
Price to Book
0.8
1.48
Price to Sales
0.35
3.96
Price to Earnings
-1.76
-7.83